PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
28.94%
Revenue growth of 28.94% while CX is flat. Bruce Berkowitz would check if a small edge can widen further.
330.73%
Gross profit growth of 330.73% while CX is zero. Bruce Berkowitz would see if minimal improvements could expand further.
1860.29%
EBIT growth of 1860.29% while CX is zero. Bruce Berkowitz would see if small gains can be scaled further.
1860.29%
Operating income growth of 1860.29% while CX is zero. Bruce Berkowitz would see if this modest edge can become significant.
186.44%
Net income growth of 186.44% while CX is zero. Bruce Berkowitz would see if small gains can accelerate into a larger gap.
186.96%
EPS growth similar to CX's 182.50%. Walter Schloss would assume both have parallel share structures and profit trends.
186.96%
Similar diluted EPS growth to CX's 182.50%. Walter Schloss might see standard sector or cyclical influences on both firms.
0.32%
Share reduction more than 1.5x CX's 7.10%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.38%
Diluted share reduction more than 1.5x CX's 7.10%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
323.43%
Positive 10Y revenue/share CAGR while CX is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
193.02%
Positive 5Y CAGR while CX is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
29.78%
Positive 3Y CAGR while CX is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
409.62%
Positive 10Y CAGR while CX is negative. John Neff might see a substantial advantage in bottom-line trajectory.
2.65%
Positive 5Y CAGR while CX is negative. John Neff might view this as a strong mid-term relative advantage.
45.54%
Below 50% of CX's 143.16%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
We cut SG&A while CX invests at 0.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.